BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 25521533)

  • 1. Response Patterns in Health State Valuation Using Endogenous Attribute Attendance and Latent Class Analysis.
    Hole AR; Norman R; Viney R
    Health Econ; 2016 Feb; 25(2):212-24. PubMed ID: 25521533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accounting for Attribute-Level Non-Attendance in a Health Choice Experiment: Does it Matter?
    Erdem S; Campbell D; Hole AR
    Health Econ; 2015 Jul; 24(7):773-89. PubMed ID: 24798402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discrete choice analysis of health worker job preferences in Ethiopia: Separating attribute non-attendance from taste heterogeneity.
    Arora N; Quaife M; Hanson K; Lagarde M; Woldesenbet D; Seifu A; Crastes Dit Sourd R
    Health Econ; 2022 May; 31(5):806-819. PubMed ID: 35178825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating willingness-to-pay for health care: A discrete choice experiment accounting for non-attendance to the cost attribute.
    Sever I; Verbič M; Sever EK
    J Eval Clin Pract; 2019 Oct; 25(5):843-849. PubMed ID: 30677196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decision heuristic or preference? Attribute non-attendance in discrete choice problems.
    Heidenreich S; Watson V; Ryan M; Phimister E
    Health Econ; 2018 Jan; 27(1):157-171. PubMed ID: 28620975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Level Overlap and Color Coding on Attribute Non-Attendance in Discrete Choice Experiments.
    Jonker MF; Donkers B; de Bekker-Grob EW; Stolk EA
    Value Health; 2018 Jul; 21(7):767-771. PubMed ID: 30005748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using conjoint analysis and choice experiments to estimate QALY values: issues to consider.
    Flynn TN
    Pharmacoeconomics; 2010; 28(9):711-22. PubMed ID: 20568837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valuing QALYs in Relation to Equity Considerations Using a Discrete Choice Experiment.
    van de Wetering L; van Exel J; Bobinac A; Brouwer WB
    Pharmacoeconomics; 2015 Dec; 33(12):1289-300. PubMed ID: 26232199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot discrete choice experiment to explore preferences for EQ-5D-5L health states.
    Norman R; Cronin P; Viney R
    Appl Health Econ Health Policy; 2013 Jun; 11(3):287-98. PubMed ID: 23649892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Not all respondents use a multiplicative utility function in choice experiments for health state valuations, which should be reflected in the elicitation format (or statistical analysis).
    Jonker MF; Norman R
    Health Econ; 2022 Feb; 31(2):431-439. PubMed ID: 34841637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. To pay or not to pay? Cost information processing in the valuation of publicly funded healthcare.
    Genie MG; Ryan M; Krucien N
    Soc Sci Med; 2021 May; 276():113822. PubMed ID: 33752103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ordinal preference elicitation methods in health economics and health services research: using discrete choice experiments and ranking methods.
    Ali S; Ronaldson S
    Br Med Bull; 2012 Sep; 103(1):21-44. PubMed ID: 22859714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valuing health for clinical and economic decisions: directions relevant for rheumatologists.
    Harrison MJ; Bansback NJ; Marra CA; Drummond M; Tugwell PS; Boonen A
    J Rheumatol; 2011 Aug; 38(8):1770-5. PubMed ID: 21807800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Willingness to pay for a QALY.
    Gyrd-Hansen D
    Health Econ; 2003 Dec; 12(12):1049-60. PubMed ID: 14673813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring health preferences for use in cost-utility and cost-benefit analyses of interventions in children: theoretical and methodological considerations.
    Prosser LA; Hammitt JK; Keren R
    Pharmacoeconomics; 2007; 25(9):713-26. PubMed ID: 17803331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating attribute non-attendance and its consequences in choice experiments with latent class models.
    Lagarde M
    Health Econ; 2013 May; 22(5):554-67. PubMed ID: 22517664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial attribute attendance in environmental choice experiments: A comparative case study between Guangzhou (China) and Brussels (Belgium).
    Hua J; Chen WY; Liekens I; Cho FHT
    J Environ Manage; 2021 May; 285():112107. PubMed ID: 33561727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Societal preferences for rheumatoid arthritis treatments: evidence from a discrete choice experiment.
    Harrison M; Marra C; Shojania K; Bansback N
    Rheumatology (Oxford); 2015 Oct; 54(10):1816-25. PubMed ID: 25989956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating health state utility values from discrete choice experiments--a QALY space model approach.
    Gu Y; Norman R; Viney R
    Health Econ; 2014 Sep; 23(9):1098-114. PubMed ID: 24943827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.